A look behind the growing cost of cancer drugs
Julie Gralow, an oncologist at the Fred Hutchinson Cancer Center in Seattle, recently prescribed an exciting new therapy for a 60-year-old woman with metastatic breast cancer. Three-and-a-half years into her battle against the disease, the patient had already exhausted three different anti-estrogen therapies, each of which only put a temporary check on the spreading tumors.
The newly prescribed drug, Novartis’ Afinitor, is one of the recently approved targeted therapies that have …
A look behind the growing cost of cancer drugs

Ovarian cancer screening clearly touches a nerve.
Test your medicine knowledge with the MKSAP challenge, in partnership with the 















